Update: FTC Ban of Noncompetes Blocked

Published in Government Relations on August 22, 2024

Noncompete blog

Earlier this year, the FTC published a final rule that sought to ban most types of noncompete agreements used by businesses in several industries, including our healthcare industry. The proposed ban would not have prohibited noncompete agreements related to the sale of a business. It would, however, have banned most noncompete agreements between businesses and most staff, which are very commonplace in the DMEPOS industry, especially for skilled or licensed/credentialed staff (ATPs, RTs, RNs, CPEDs, etc.). 

Their final rule was published in April, and the ban on noncompete agreements was scheduled to go into effect in September of 2024. VGM published a summary of the final rule in May. As we mentioned in our summary of the final rule, the noncompete ban was met immediately with legal challenges from entities and industries alike. On Tuesday, August 20, Judge Ada Brown, a federal judge from the U.S. District Court in Texas, ruled that the FTC overstepped their statutory authority in the final rule and said that the ban was “arbitrary and capricious,” unreasonably overbroad, and lacked a reasonable explanation.” Judge Brown also cited that the ban in its proposed form would cause irreparable harm. 

The ruling this week means that the ban on noncompete agreements cannot and will not go into effect in September. The FTC has not yet said whether they will appeal the decision, but Victoria Graham, a spokesperson for the FTC, said they are considering that option. The FTC could also choose to address noncompete agreements in a different manner, perhaps through enforcement actions. 

If this is appealed further and based on some conflicting rulings in other states regarding noncompete agreements, it is possible this issue could make it to the Supreme Court. For the time being, companies are still at liberty to utilize noncompete agreements in their day-to-day business dealings with their employees. VGM will continue to monitor this topic and will issue further communications regarding any changes in the enforceability, timeline, or anything else related to this ban of noncompete agreements.

If you have questions or need additional information, please reach out to craig.douglas@vgm.com or alan.morris@vgm.com.


TAGS

  1. dmepos
  2. legislation
  3. vgm government

From Our Experts

New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries thumbnail New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME), Cochairs of the Senate Diabetes Caucus, have introduced the Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act, S.4037. VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center thumbnail VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center VGM Government Relations is proud to announce the reintroduction of its Fraud, Waste & Abuse (FWA) Reporting Resource Center—a newly refreshed online hub designed to protect the integrity of the DMEPOS industry and reinforce our unwavering commitment to ethical, compliant care. Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical thumbnail Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical We're proud to once again recognize a true Champion of Change in the DME industry: Thom Harvill of Above and Beyond Medical in Tennessee. Thom has dedicated many years to the DME community—consistently showing up, speaking out, and pushing the industry forward. He's the kind of advocate who never stops asking, “Who else can I reach out to about this?” Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart.